Cirrhosis is known to have a high prevalence and mortality worldwide, especially for those decompensated cirrhosis with portal hypertension. A certain amount of patients deteriorate with known or unknown precipitants, and develop acute-on-chronic liver failure, which has a high short-term mortality.
University Hospital Frankfurt, Germany
MD student (2019–present)
University Hospital Münster, Germany
MD/PhD candidate (2022–present)
Carl Anton Ewald-Preis, Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)
2021
European Foundation for the Study of
Chronic Liver Failure
Travessera de Gràcia 11, 7th floor
08021 Barcelona, Spain
© European Foundation for the Study of Chronic Liver Failure 2024